Growth Metrics

Uxin (UXIN) Cost of Revenue (2017 - 2025)

Uxin filings provide 9 years of Cost of Revenue readings, the most recent being $17.5 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 106.62% to $17.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $36.4 million, a 6.22% decrease, with the full-year FY2025 number at $50.0 million, up 59.95% from a year prior.
  • Cost of Revenue hit $17.5 million in Q4 2025 for Uxin, up from $12741.9 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $10.7 billion in Q4 2021 to a low of $9.83 in Q2 2022.
  • Median Cost of Revenue over the past 5 years was $7.5 million (2024), compared with a mean of $883.5 million.
  • Biggest five-year swings in Cost of Revenue: crashed 100.0% in 2022 and later surged 482386313.09% in 2023.
  • Uxin's Cost of Revenue stood at $10.7 billion in 2021, then crashed by 100.0% to $7967.0 in 2022, then rose by 0.21% to $7984.0 in 2023, then surged by 105912.02% to $8.5 million in 2024, then skyrocketed by 106.62% to $17.5 million in 2025.
  • The last three reported values for Cost of Revenue were $17.5 million (Q4 2025), $12741.9 (Q3 2025), and $10.4 million (Q2 2025) per Business Quant data.